BACKGROUND: There are no data on directly measured cardiorespiratory fitness combined coronary risk evaluation with respect to death from cardiovascular diseases and all-causes. We investigated the prognostic significance of risk scores and cardiorespiratory fitness with respect to cardiovascular disease and all-cause mortality. METHODS: Cardiorespiratory fitness (maximal oxygen uptake, VO2peak) was measured by exercise test with an electrically braked cycle ergometer. The study is based on a random population-based sample of 1639 men (42-60 years) without history of type 2 diabetes or atherosclerotic cardiovascular diseases. RESULTS: During an average follow-up of 16 years, a total of 304 deaths occurred. Independent predictors for all-cause death were European Score (for 1% increment, RR 1.15, 95% CI 1.10-1.20), VO2peak (for 1 MET increment, RR 0.84, 95% CI 0.78-0.89), when adjusted for C-reactive protein, alcohol consumption, serum high-density lipoprotein, waist-to-hip ratio, family history of coronary heart disease, exercise-induced ST changes and the use of medications for hypertension, dyslipidaemia or aspirin. Also, Framingham risk score was related to the risk of death (RR 1.05, 95% CI 1.03-1.07, P < 0.001). Subjects with high European or Framingham score and low VO2peak represent the highest risk group. CONCLUSION: An important finding is that the risk scores can be used to identify men for whom low cardiorespiratory fitness predicts an especially high risk for death from cardiovascular and any other cause.
BACKGROUND: There are no data on directly measured cardiorespiratory fitness combined coronary risk evaluation with respect to death from cardiovascular diseases and all-causes. We investigated the prognostic significance of risk scores and cardiorespiratory fitness with respect to cardiovascular disease and all-cause mortality. METHODS:Cardiorespiratory fitness (maximal oxygen uptake, VO2peak) was measured by exercise test with an electrically braked cycle ergometer. The study is based on a random population-based sample of 1639 men (42-60 years) without history of type 2 diabetes or atherosclerotic cardiovascular diseases. RESULTS: During an average follow-up of 16 years, a total of 304 deaths occurred. Independent predictors for all-cause death were European Score (for 1% increment, RR 1.15, 95% CI 1.10-1.20), VO2peak (for 1 MET increment, RR 0.84, 95% CI 0.78-0.89), when adjusted for C-reactive protein, alcohol consumption, serum high-density lipoprotein, waist-to-hip ratio, family history of coronary heart disease, exercise-induced ST changes and the use of medications for hypertension, dyslipidaemia or aspirin. Also, Framingham risk score was related to the risk of death (RR 1.05, 95% CI 1.03-1.07, P < 0.001). Subjects with high European or Framingham score and low VO2peak represent the highest risk group. CONCLUSION: An important finding is that the risk scores can be used to identify men for whom low cardiorespiratory fitness predicts an especially high risk for death from cardiovascular and any other cause.
Authors: Nicholas R Lamoureux; John S Fitzgerald; Kevin I Norton; Todd Sabato; Mark S Tremblay; Grant R Tomkinson Journal: Sports Med Date: 2019-01 Impact factor: 11.136
Authors: Jonathan A Mitchell; Daniel B Bornstein; Xuemei Sui; Steven P Hooker; Timothy S Church; Chong D Lee; Duck-Chul Lee; Steven N Blair Journal: Am Heart J Date: 2010-07 Impact factor: 4.749
Authors: Sachin Gupta; Anand Rohatgi; Colby R Ayers; Benjamin L Willis; William L Haskell; Amit Khera; Mark H Drazner; James A de Lemos; Jarett D Berry Journal: Circulation Date: 2011-03-21 Impact factor: 29.690
Authors: Emmanuel Stamatakis; Mark Hamer; Gary O'Donovan; George David Batty; Mika Kivimaki Journal: Eur Heart J Date: 2012-05-03 Impact factor: 29.983
Authors: Jennifer C Richards; Mark C Lonac; Tyler K Johnson; Melani M Schweder; Christopher Bell Journal: Med Sci Sports Exerc Date: 2010-04 Impact factor: 5.411
Authors: Lars Rödjer; Ingibjörg H Jonsdottir; Annika Rosengren; Lena Björck; Gunnar Grimby; Dag S Thelle; Georgios Lappas; Mats Börjesson Journal: BMC Public Health Date: 2012-08-24 Impact factor: 3.295